| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-8703(74)90184-7 |
| P8608 | Fatcat ID | release_5s273pthtvantbiywhjw7yfe4y |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0002870374901847?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0002870374901847?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 4817114 |
| P2093 | author name string | J. M. Holt | |
| M. L. Snaith | |||
| P2860 | cites work | Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil | Q28363829 |
| Immunosuppressive therapy. The relation between clinical response and immunologic competence | Q33461697 | ||
| Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis | Q33626928 | ||
| Cyclophosphamide in lupus nephritis: a controlled trial | Q34201904 | ||
| The natural history of systemic lupus erythematosus by prospective analysis | Q39866953 | ||
| Characteristic Features of Immunosuppression by Steroids and Cytotoxic Drugs | Q44943231 | ||
| The clinical course of the proliferative and membranous forms of lupus nephritis. | Q47728168 | ||
| Marrow granulocyte reserves in the rheumatic diseases | Q47995885 | ||
| Correlation of a Precipitin Reaction to an RNA-Protein Antigen and a Low Prevalence of Nephritis in Patients with Systemic Lupus Erythematosus | Q54417959 | ||
| CYCLOPHOSPHAMIDE TREATMENT OF KIDNEY DISEASE IN (NZB X NZW) F1 MICE | Q56019731 | ||
| Cyclophosphamide in Treatment of Systemic Lupus Erythematosus: 7 Years' Experience | Q69538840 | ||
| Toxicity of immunosuppressive drugs in man | Q69578572 | ||
| Sterility and cyclophosphamide | Q70000253 | ||
| Effect of Azathioprine on Renal Histology and Function in Lupus Nephritis | Q70580205 | ||
| Nitrogen mustard in treatment of systemic lupus erythematosus | Q73452452 | ||
| DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE | Q76702890 | ||
| DRUGS EMPLOYED FOR THE SUPPRESSION OF IMMUNOLOGIC RESPONSIVENESS | Q78314982 | ||
| Clinical evaluation of CB 1348 in malignant lymphoma and related diseases | Q78544390 | ||
| Clinical evaluation of CB 1348 in leukemias and lymphomas | Q78544407 | ||
| The clinical use of chlorambucil: a critical study | Q78837757 | ||
| Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis | Q78976556 | ||
| Sterility and testicular atrophy related to cyclophosphamide therapy | Q93716977 | ||
| Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome | Q93723730 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chlorambucil | Q415939 |
| Cardiology and cardiovascular medicine | Q96320350 | ||
| P304 | page(s) | 533-535 | |
| P577 | publication date | 1974-04-01 | |
| P1433 | published in | American Heart Journal | Q2227156 |
| P1476 | title | Chlorambucil in the treatment of systemic lupus erythematosus | |
| P478 | volume | 87 |
Search more.